Publications by authors named "Philippe Tangre"

Claim this Profile
C
Cardiologist follow-up and improved outcomes of heart failure: a French nationwide cohort.
Guillaume Baudry, Ouarda Pereira, François Roubille, Marc Villaceque, Thibaud Damy, Philippe Tangre

Eur Heart J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, sociodemographic characteristics and spatial distribution of systemic lupus erythematosus in France: a nationwide study using health claims data with insights into hydroxychloroquine prescription patterns.
Jacques Pouchot, Laurence Mandereau-Bruno, Delphine Serra, Philippe Tangre, Panayotis Constantinou

Lupus Sci Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-based differences in heart failure management and outcomes: Insights from the French-DataHF cohort.
Guillaume Baudry, Ouarda Pereira, François Roubille, Marc Villaceque, Thibaud Damy, Philippe Tangre

Eur J Heart Fail· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Optimizing care pathways for IC patients in local areas: the Outil'IC initiative].
Philippe Tangre

Soins· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of readmission and death after hospitalization for worsening heart failure: Role of post-discharge follow-up visits in a real-world study from the Grand Est Region of France.
Guillaume Baudry, Ouarda Pereira, Kévin Duarte, João Pedro Ferreira, Gianluigi Savarese, Philippe Tangre

Eur J Heart Fail· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of lamivudine or emtricitabine is associated with reduced emergence of nonnucleoside reverse transcriptase inhibitor mutations in an efavirenz-based intermittent antiretroviral treatment regimen.
Stéphanie Trancart, Isabelle Charreau, Bruno Marchou, Muriel Bocquentin, Jean-Michel Molina, Philippe Tangre

Antimicrob Agents Chemother· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minor HIV-1 variants with the K103N resistance mutation during intermittent efavirenz-containing antiretroviral therapy and virological failure.
Pierre Delobel, Adrien Saliou, Florence Nicot, Martine Dubois, Stéphanie Trancart, Philippe Tangre

PLoS One· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and risk factors of thrombocytopenia in patients receiving intermittent antiretroviral therapy: a substudy of the ANRS 106-window trial.
Marie-Anne Bouldouyre, Isabelle Charreau, Bruno Marchou, Philippe Tangre, Christine Katlama

J Acquir Immune Defic Syndr· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs of intermittent versus continuous antiretroviral therapy in patients with controlled HIV infection: a substudy of the ANRS 106 Window Trial.
Isabelle Charreau, Grégoire Jeanblanc, Philippe Tangre, Laurence Boyer, Marine Saouzanet

J Acquir Immune Defic Syndr· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response.
Jacques Izopet, Bruno Marchou, Isabelle Charreau, Karine Sauné, Philippe Tangre

Antivir Ther· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermittent antiretroviral therapy in patients with controlled HIV infection.
Bruno Marchou, Philippe Tangre, Isabelle Charreau, Jacques Izopet, Pierre-Marie Girard

AIDS· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience using MedDRA for global events coding in HIV clinical trials.
Christine Tonéatti, Yacine Saïdi, Vincent Meiffrédy, Philippe Tangre, Marine Harel

Contemp Clin Trials· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis